We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TVA:NASDAQTexas Ventures Acquisition III Corp Analysis

Data as of 2026-05-28 - not real-time

$10.51

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Texas Ventures Acquisition III Corp (TVA) trades at $10.51, tightly sandwiched between the 20‑day SMA (10.50) and the 50‑day SMA (10.44), with the 200‑day SMA (10.57) only marginally higher, indicating a flat price environment. The RSI sits at 57.6, suggesting neither overbought nor oversold conditions, while the MACD shows a bearish signal with a slight negative histogram. Support at $10.47 and resistance at $10.55 frame the current price, reinforcing a neutral technical outlook. Fundamentally, the stock appears overvalued – a trailing PE of 43.8 dwarfs the industry average of 16.6, and a negative price‑to‑book of -22.4 reflects a lack of tangible equity. The company holds minimal cash ($0.86 M) and negative operating and free cash flow, underscoring the speculative nature of this SPAC. Recent news of discussions with Trump Media & Technology Group adds a potential catalyst, but the outcome remains uncertain.
Given the low beta (0.22) and modest 30‑day volatility (4.4%), market‑wide swings have limited impact, yet the sector (Shell Companies/SPAC) carries inherent high risk. With no dividend, no earnings growth, and a max drawdown of -11.5%, investors should treat TVA as a high‑risk, speculative play pending a definitive business combination.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering between support and resistance
  • Neutral technical indicators (RSI, SMA alignment)
  • Pending merger discussion adds uncertainty

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Overvalued valuation metrics (PE, PB)
  • Lack of operating revenue or cash flow
  • Potential catalyst from merger talks but no guarantee

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Fundamental deficiencies (negative book value, zero earnings)
  • High sector risk for shell companies/SPACs
  • No dividend and limited upside without a successful business combination

Key Metrics & Analysis

Financial Health

P/E Ratio43.8
ROA-0.39%
P/B Ratio-22.4
Op. Cash Flow$-437989
Free Cash Flow$-436176
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI57.6
Support$10.47
Resistance$10.55
MA 20$10.50
MA 50$10.44
MA 200$10.57
MACDBearish
VolumeStable
Fear & Greed Index92.34

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.22
Volatility4.39%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.